11:14 AM EDT, 07/05/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.53% to 1,446.18 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Grifols ( GRFS ) , which climbed 6.6% and 5.7% respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and pharmaceutical company Novo Nordisk ( NVO ) , which increased 3.5% and 1.9% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS ( EDAP ) and petroleum refiner Equinor ( EQNR ) , which fell 1.4% and 1.2% respectively. They were followed by biopharmaceutical company Calliditas Therapeutics ( CALT ) and furniture maker Natuzzi (NTZ), which were off 0.8% each.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and medical device maker Smith & Nephew ( SNN ) , which rose 8.8% and 7.3% respectively. They were followed by biopharmaceutical company Amarin ( AMRN ) and financial services company Lloyds Banking Group ( LYG ) , which rose 4.8% and 3.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm ( TCBP ) and insurance firm Prudential (PUK), which fell 7.4% and 2.3% respectively. They were followed by cruise line operator Carnival (CUK) and hospitality company InterContinental Hotels Group ( IHG ) , which were down 2.2% and 1.5% respectively.